TipRanks
Go Ultimate55% OFF

Spero Therapeutics (SPRO) Q4 2018 Earnings Report

603 Followers

SPRO Q4 2018 EPS Results

Actual EPS
-$0.60
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$1.59

SPRO Q4 2018 Revenue Results

Actual Revenue
$1.69M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2018
Date
03/14/2019
Time
After Close
Conference Call
Thursday, March 14, 2019
SPRO Upcoming Earnings

Spero Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q4 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

SPRO Earnings History

SPRO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 16, 20262026 (Q3)-0.47--0.13――
Aug 12, 20262026 (Q2)―-0.16-0.03-433.33% (-0.13)
May 13, 20262026 (Q1)―-0.13-0.2548.00% (+0.12)
Mar 26, 20262025 (Q4)-0.200.53-0.38239.47% (+0.91)
Nov 13, 20252025 (Q3)-0.25-0.13-0.3259.38% (+0.19)
Aug 12, 20252025 (Q2)-0.38-0.03-0.3390.91% (+0.30)
May 13, 20252025 (Q1)-0.55-0.25-0.24-4.17% (-0.01)
Mar 27, 20252024 (Q4)-0.31-0.380.96-139.58% (-1.34)
Nov 14, 20242024 (Q3)-0.27-0.32-0.06-433.33% (-0.26)
Aug 05, 20242024 (Q2)-0.38-0.33-0.23-43.48% (-0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed